Efficacy and safety of catheter ablation for paroxysmal atrial fibrillation as first-line therapy vs. after drug failure -analysis from Japan Nationwide Ablation (J-AB) Registry-

2 September 2024 (15:00 - 15:15)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Jun Oikawa

Kitasato University Graduate School of Medical Sciences, Sagamihara (Japan)

3 More presentations in this session

Presentation thumbnail

Catheter ablation increases cerebral blood flow and cognitive function in elderly patients with atrial fibrillation

Doctor M. Manita (Naha, JP)

Abstract Slides Video

Presentation thumbnail

Effect of catheter ablation in atrial fibrillation patients irrespective of their baseline heart failure: An updated meta-analysis.

Doctor A. Helmi (Alexandria, EG)

Abstract Slides Video

Presentation thumbnail

improvement of left atrial function after ablation in patients with paroxysmal atrial fibrillation is associated with the presence of heart failure with preserved ejection fraction

Ms K. Sun (Beijing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Catheter ablation for atrial fibrillation: relevance of concomitant therapies and comorbidities

The Event

Event poster

ESC Congress 2024

2 September 2024 15:00 CET

You may be interested in

Congress Session

Catheter ablation for atrial fibrillation: relevance of concomitant therapies and comorbidities

Congress Presentation

Catheter ablation as first versus second-line therapy for atrial fibrillation: a frequentist and bayesian meta-analysis with reconstructed time-to-event and trial sequential analysis

Congress Session

Atrial fibrillation catheter ablation (1)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources